Experimental drug targets early toxic amyloid to slow Alzheimer’s disease
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer’s disease.
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer’s disease.